Mechanistic comparison of Dimethyl Fumarate and alyssin [Supplementary Concept] based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
3
Shared Targets
23%
Jaccard Similarity
20%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Dimethyl and alyssin share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.231 means 23% of the combined target set is bound by both compounds. The IDF-weighted score of 0.195 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Dimethyl and alyssin have in common?
Dimethyl and alyssin share 3 molecular targets with a Jaccard similarity of 23%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Dimethyl and alyssin be combined?
Dimethyl and alyssin share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Dimethyl or alyssin?
In the BiohacksAI corpus: Dimethyl has 296 PubMed-indexed studies, alyssin has 300 studies.